Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Anuh Pharma Limited has informed the Exchange about orders passed regarding Assessment Order received under Section 143(3) read with Section 263 and ...more...
As of December 2025 71.82% is owned by Promoters and 28.18% by Public. Among Promoters holding Indian Promoters holds 71.80% and Foreign Pro...more...
Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st Dece...more...
Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
Anuh Pharma Limited has informed the Exchange regarding Approval from EDQM for CEP of Sulfadimethoxine.more...
Approval from EDQM for CEP of Sulfadimethoxine.more...
Anuh Pharma Limited has informed the Exchange about Investor Presentationmore...
Investor Presentation for Q2 FY 2025-26more...
Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-Audited financial results for the Quarter and Ha...more...
Adoption of Revised Policies and Codesmore...
Anuh Pharma Limited has informed the Exchange about General Updates for updation of revised Polices and Codes.more...
Anuh Pharma Limited has informed the Exchange regarding the approval of Un-audited Financial Results for the period ended September 30 2025 and Adopt...more...
Anuh Pharma Limited has submitted to the Exchange regarding the approval of Un-audited Financial Results for the period ended September 30 2...more...
Unaudited Financial Results for the quarter and half year ended 30th September 2025more...
The company reported standalone net profit of Rs 7.61 crore for the quarter ended September 30 2025 as compared to Rs 15.04 crore in the sam...more...
To consider and approve the Un-audited Financial results along with Limited Review Report for the quarter and half year ended 30th September 2025 and...more...
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider ...more...
As of September 2025 71.82% is owned by Promoters and 28.18% by Public. Among Promoters holding Indian Promoters holds 71.80% and Foreign Promoters h...more...
BOARD MEETINGS Company Name : Aarti Industries Date : 02-02-2026